Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorHong Kong Baptist University
About this trial
In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
Eligibility criteria
Qualifiers
meet the clinical diagnosis of Long COVID by the World Health Organization (WHO), with no neuropsychiatric symptoms 1 year before infection with Covid-19, and continue to have at least one neuropsychiatric symptom for 2 months after SARS-CoV-2 turned negative 3 months above;
aged 12 to 80 years;
willing and able to consent, and complete all assessment and study procedures
Disqualifiers
patients with a history of chronic neuropsychiatric symptoms;
cardiovascular diseases pre-existing to the Covid-19 episode such as arrhythmia, heart failure, myocardial infarction, and patients with cardiac pacemakers;
documented pre-existing history of psychiatric illness, including substance abuse;
suicidal tendencies (attempted suicide in the 12 months before the study);
Trial design
Treatments tested in this trial
- Acupuncture
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov